296 related articles for article (PubMed ID: 24768351)
1. [Failure of amiodarone in supraventricular tachycardia in an infant: drug interaction with Gaviscon(®)?].
Chantepie A; Lefort B; Méot M; Jandali JC; Soulé N; Chantreuil J; Vaillant MC; Tisseron B
Arch Pediatr; 2014 Jun; 21(6):663-4. PubMed ID: 24768351
[No Abstract] [Full Text] [Related]
2. [Gastroesophageal reflux disease during pregnancy].
Elokhina TB; Tiutiunnik VL
Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
[No Abstract] [Full Text] [Related]
3. [Estimation of efficiency of alginate-raft barrier in treatment of gastroesophageal reflux disease].
Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
Eksp Klin Gastroenterol; 2008; (6):77-81. PubMed ID: 19334430
[No Abstract] [Full Text] [Related]
4. Randomised clinical trial: addition of alginate-antacid (Gaviscon Double Action) to proton pump inhibitor therapy in patients with breakthrough symptoms.
Coyle C; Crawford G; Wilkinson J; Thomas SJ; Bytzer P
Aliment Pharmacol Ther; 2017 Jun; 45(12):1524-1533. PubMed ID: 28464343
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial: a double-blind, placebo-controlled study to assess the clinical efficacy and safety of alginate-antacid (Gaviscon Double Action) chewable tablets in patients with gastro-oesophageal reflux disease.
Wilkinson J; Wade A; Thomas SJ; Jenner B; Hodgkinson V; Coyle C
Eur J Gastroenterol Hepatol; 2019 Jan; 31(1):86-93. PubMed ID: 30272584
[TBL] [Abstract][Full Text] [Related]
6. [Alginate-containing preparation gaviscon for patients with gastroesophaginal reflux complicated with chronic pancreatitis: pathogenetic substantiation of clinical use prospects].
Uspenskiĭ IuP; Pakhomova IG; Bubiakina VN
Eksp Klin Gastroenterol; 2008; (1):96-101. PubMed ID: 19145860
[No Abstract] [Full Text] [Related]
7. Raised plasma aluminium in an infant on antacid.
Puntis JW; Ballantine NE; Durbin GM
Lancet; 1989 Oct; 2(8668):923. PubMed ID: 2571845
[No Abstract] [Full Text] [Related]
8. [Gaviscon].
Ménégol-Couque B; Brard M
Soins; 1985 Jun; (455):I-II. PubMed ID: 2994235
[No Abstract] [Full Text] [Related]
9. Gaviscon: not always entirely safe!
Shenvi A
BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23329718
[No Abstract] [Full Text] [Related]
10. [Alginate-raft preparations in the treatment of acid reflux and heartburn (literature review)].
Mandel KG; Deggi BP; Brodi DA; Jeykobi GI
Eksp Klin Gastroenterol; 2008; (4):64-77. PubMed ID: 19145905
[No Abstract] [Full Text] [Related]
11. Gaviscon bezoars.
Sorbie AL; Symon DN; Stockdale EJ
Arch Dis Child; 1984 Sep; 59(9):905-6. PubMed ID: 6091569
[No Abstract] [Full Text] [Related]
12. [Using gaviscon preparation for relief of esophageal, extraesophageal syndromes and functional dyspepsia in elderly patients with GERD].
Onuchina EV; Brikova SI; Tsukanov VV
Eksp Klin Gastroenterol; 2010; (10):80-6. PubMed ID: 21434379
[TBL] [Abstract][Full Text] [Related]
13. The mode of action and complications of Infant Gaviscon.
Keipert JA
Aust Paediatr J; 1979 Dec; 15(4):263-5. PubMed ID: 44677
[No Abstract] [Full Text] [Related]
14. [Gaviscon in reflux symptoms. Results of a drug monitoring study].
Hutt HJ; Tauber O; Flach D
Fortschr Med; 1990 Oct; 108(31):598-600. PubMed ID: 2258131
[TBL] [Abstract][Full Text] [Related]
15. [The experience of usage of alginate contain medication in complex therapy at children with GERD disease].
Shcherbakov PL; Lobanov IuF; Fugol DS; Shilova AV
Eksp Klin Gastroenterol; 2009; (5):81-4. PubMed ID: 20201310
[TBL] [Abstract][Full Text] [Related]
16. [Multicenter study of sodium alginate in the treatment of regurgitation in infants].
Le Luyer B; Mougenot JF; Mashako L; Chapoy P; Olives JP; Morali A; Chevallier B; Ginies JL; Dupont C; Dagorne M
Ann Pediatr (Paris); 1992 Dec; 39(10):635-40. PubMed ID: 1485782
[TBL] [Abstract][Full Text] [Related]
17. [Alginate improves symptom control].
Siegmund-Schultze N
MMW Fortschr Med; 2016 Jun; 158(11):76. PubMed ID: 27271425
[No Abstract] [Full Text] [Related]
18. Randomised clinical trial: relief of upper gastrointestinal symptoms by an acid pocket-targeting alginate-antacid (Gaviscon Double Action) - a double-blind, placebo-controlled, pilot study in gastro-oesophageal reflux disease.
Thomas E; Wade A; Crawford G; Jenner B; Levinson N; Wilkinson J
Aliment Pharmacol Ther; 2014 Mar; 39(6):595-602. PubMed ID: 24471505
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of action, efficacy, and onset dynamics of a single dose of alginates in patients with heartburn and GERD].
Bordin DS; Masharova AA; Firsova LD; Kozhurina TS; Safonova OV
Eksp Klin Gastroenterol; 2009; (4):77-85. PubMed ID: 19960998
[TBL] [Abstract][Full Text] [Related]
20. Gaviscon® Advance alone versus co-prescription of Gaviscon® Advance and proton pump inhibitors in the treatment of laryngopharyngeal reflux.
Wilkie MD; Fraser HM; Raja H
Eur Arch Otorhinolaryngol; 2018 Oct; 275(10):2515-2521. PubMed ID: 30062580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
